Your browser is no longer supported. Please, upgrade your browser.
NanoVibronix, Inc.
Index- P/E- EPS (ttm)-0.37 Insider Own12.15% Shs Outstand24.78M Perf Week-4.97%
Market Cap44.53M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float21.18M Perf Month-16.50%
Income-7.10M PEG- EPS next Q- Inst Own4.90% Short Float2.12% Perf Quarter129.43%
Sales0.70M P/S63.62 EPS this Y69.50% Inst Trans- Short Ratio0.02 Perf Half Y85.85%
Book/sh0.17 P/B10.12 EPS next Y- ROA-101.70% Target Price- Perf Year132.81%
Cash/sh0.22 P/C7.81 EPS next 5Y- ROE-199.40% 52W Range0.54 - 4.19 Perf YTD125.10%
Dividend- P/FCF- EPS past 5Y22.00% ROI-195.50% 52W High-58.95% Beta0.17
Dividend %- Quick Ratio16.30 Sales past 5Y33.50% Gross Margin62.00% 52W Low218.52% ATR0.18
Employees11 Current Ratio16.80 Sales Q/Q0.00% Oper. Margin- RSI (14)43.26 Volatility8.43% 9.01%
OptionableNo Debt/Eq0.00 EPS Q/Q97.50% Profit Margin- Rel Volume0.08 Prev Close1.66
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume24.26M Price1.72
Recom2.00 SMA20-6.27% SMA50-24.37% SMA20022.93% Volume1,939,533 Change3.61%
Oct-11-21 10:40AM  
Sep-29-21 10:14AM  
Sep-14-21 12:12PM  
Aug-17-21 02:32PM  
Aug-16-21 04:05PM  
Aug-11-21 08:30AM  
Aug-05-21 08:52AM  
Jul-29-21 09:00AM  
Jul-26-21 10:47AM  
Jul-23-21 03:03PM  
Jul-22-21 08:15AM  
Jun-03-21 08:30AM  
Apr-27-21 11:17AM  
Apr-26-21 09:00AM  
Apr-19-21 09:50AM  
Apr-14-21 12:57PM  
Mar-31-21 06:50PM  
Mar-02-21 08:30AM  
Feb-10-21 08:00AM  
Feb-03-21 08:00AM  
Jan-22-21 11:12AM  
Jan-19-21 08:00AM  
Dec-11-20 08:00AM  
Dec-08-20 08:00AM  
Dec-07-20 05:10PM  
Dec-02-20 01:01PM  
Nov-16-20 06:12PM  
Oct-16-20 08:30AM  
Oct-08-20 09:00AM  
Sep-29-20 08:49AM  
Sep-22-20 08:36PM  
Aug-27-20 03:42PM  
Aug-24-20 10:58PM  
Aug-13-20 08:30AM  
Jul-07-20 08:00AM  
Jun-16-20 08:00AM  
Jun-01-20 08:00AM  
Apr-02-20 11:06AM  
Apr-01-20 08:00AM  
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.